En Es
Categories

Industry News

Blood Testing Market Surpasses USD 2 Billion in 2016

By Labmedica International staff writers
16 Jun 2017

Image: The global market for blood testing and typing products reached USD 2.6 billion in 2016 (Photo courtesy of iStock).The global market for blood testing and typing products used in blood banking/donations of pooled blood reached USD 2.6 billion in 2016, although blood banking is not a fast-growing market and tends to grow only when new diseases are added to testing menu. These are the latest findings of Kalorama Information (New York, NY, USA), an independent medical market research firm.

In its study of the testing markets amidst increased vigilance by U.S. health authorities and cases of Zika and other diseases, Kalorama found three common types of tests related to blood banking:

Immunoassays for HIV, hepatitis B, hepatitis C and syphilis are routinely used to test blood units for blood borne infectious agents. In Latin America, all blood banks also screen donated units for Chagas disease while in some developing countries, blood banks undertake additional screening for Dengue fever and malaria, which are common and deadly in several tropical nations.

Blood grouping and typing reagents and instruments are used by blood transfusion services, hospital and private blood banks and hospital laboratories that prepare blood units for transfusion to patients. Blood bank lab systems require blood tracking to avoid the possibility of the serious error of administering the wrong blood type to a patient.

Nucleic acid testing (NAT) allows blood banks to detect viral contamination, including West Nile Virus, HIV and hepatitis C, sooner and stop them from slipping into blood transfusions, thus making NAT an integral part of efforts to make blood transfusions safer. An estimated 53 million units of blood are screened using NAT. The commonly used NAT assays detect HIV-1 RNA, HCV RNA, HBV DNA, and West Nile Virus (WNV) RNA, and are used to test for West Nile virus, HIV and HCV in almost all the blood drawn in North America, Europe and Japan.

“Although no dramatic change in the testing industry is expected, new guidelines and disease concerns make it a worthwhile time for business planners to revisit test market assumptions,” said Bruce Carlson, Publisher of Kalorama Information.

Related Links:
Kalorama Information



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

17 Oct 2017
Ortho Clinical Diagnostics and EKF Diagnostics Collaborate for Assay
Ortho Clinical Diagnostics and EKF Diagnostics have entered into an agreement that allows Ortho customers to access the Beta-Hydroxybutyrate (BHB) assay, an important marker used in conjunction with clinical findings and other lab tests for the diagnosis and management of ketoacidosis and its main causative factor, diabetic ketoacidosis (DKA). The fully automated assay is now available for use on Ortho's VITROS 4600 chemistry system and the VITROS 5600 integrated system.
Read More
16 Oct 2017
Release of X-Ray Database to Boost AI Research
The U.S. National Institutes of Health (NIH) recently made available a massive database of chest X-rays, marking a huge step toward integrating artificial intelligence (AI) mechanisms into clinical practice.
Read More
16 Oct 2017
BioVendor Acquires All Shares of DIAsource ImmunoAssays SA
BioVendor - Laboratornímedicínaa.s., an international diagnostics holding, has acquired 100% of the shares of DIAsourceImmunoAssays SA from Anteo Diagnostics, which had acquired DIAsource in January 2016.
Read More
16 Oct 2017
Handheld Scanners Market to Reach USD 725 Million by 2027
The global handheld ultrasound scanners market is projected to grow at a robust CAGR of 8.8% from around USD 311 million in 2017 to about USD 725 million by 2027 end, driven mainly by the increasing use of handheld ultrasound scanners among non-radiologists and modernization in healthcare, coupled with high investment in research and development (R&D).
Read More
16 Oct 2017
Siemens Healthineers Enters Agreement with HORIBA Medical
Siemens Healthineers and HORIBA Medical have entered into a long-term agreement to bring new and innovative hematology solutions to the market globally.
Read More
11 Oct 2017
Abbott Closes Acquisition of Alere
Abbott has closed the acquisition of Alere, Inc., following the receipt of all regulatory clearances required for the closing.
Read More
11 Oct 2017
Companies with Lab-Developed Tests Raise USD 2 Billion
Companies with laboratory-developed tests (LTDs), tests performed by laboratories owned by IVD companies and others, are attracting increasing investor interest and raised over USD 2 billion between January and August 2017. These are the latest findings of Kalorama Information, an independent medical market research firm.
Read More
10 Oct 2017
IBM Watson Uses AI to Determine Patients Who Need Contrast
Researchers at the University of California, San Francisco (UCSF) have discovered that IBM Watson can help optimize the process of determining which patients need contrast for musculoskeletal MRI scans.
Read More
10 Oct 2017
Toshiba to Change Name to Canon in January
Toshiba Medical Systems Corporation will change its company name to Canon Medical Systems Corporation on January 4, 2018. The decision by Toshiba Medical to change the company’s name comes after it officially became a subsidiary of Canon Inc. in December 2016.
Read More
Copyright © 2000-2017 TradeMed.com. All rights reserved. | Terms And Conditions